Goodwin Steers Mass Spectrometry Biz Eyeing $75M IPO

Law360 (November 25, 2020, 5:15 PM EST) -- Mass spectrometry company 908 Devices on Wednesday filed for an initial public offering guided by Goodwin Procter LLP that is preliminarily estimated to bring in about $75 million.

Boston-headquartered 908 Devices Inc. did not specify how many shares it plans to sell or at what price, but estimated a maximum offering size of about $75 million when calculating its registration fees. 908 Devices focuses on making measurement instruments for chemical and biochemical analysis and research, saying it is "democratizing" laboratory mass spectrometry devices.

"We have developed an innovative suite of purpose-built handheld and desktop mass spectrometry … devices for the point-of-need,"...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!